跳至主要内容
临床试验/NCT05796518
NCT05796518已完成不适用

A Pilot Study to Examine Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2023年9月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
44
试验地点
1
主要终点
Number of Participants to Complete Intervention - Feasibility

研究概览

简要总结

Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.

详细描述

Primary Objective: The primary objective of this pilot study is to assess the feasibility of enrolling and completing the heart health assessment among endometrial cancer patients scheduled for routine follow-up care.

Secondary Objectives:

  • To assess patient satisfaction with the tool.
  • To identify the proportion of patients with non-ideal cardiovascular health scores who report initiating discussions regarding cardiovascular health during their routine oncology appointment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer
  • •Greater than or equal to 3 months post-potentially curative cancer treatment
  • •Patients must be at least 18 years of age
  • •Have a working email address
  • •Comfortable reading medical information in English, as per self-report

排除标准

  • •Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer)
  • •Have a history of endometrial cancer recurrence
  • •Enrolled in hospice care or documentation of life expectancy < 6 months

研究组 & 干预措施

PREVENT - Cardiovascular Health Assessment Tool

Experimental

An adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).

干预措施: Interview Regarding Heart Health (Other)

PREVENT - Cardiovascular Health Assessment Tool

Experimental

An adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).

干预措施: PREVENT Cardiovascular Health Assessment Tool (Other)

PREVENT - Cardiovascular Health Assessment Tool

Experimental

An adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).

干预措施: Survey (Other)

结局指标

主要结局

Number of Participants to Complete Intervention - Feasibility

时间窗: 6 months

Feasibility will be defined from the number of participants who complete the web-based assessment using exact 95% binomial confidence intervals.

次要结局

  • Number of Participants to Report Initiating Discussions Regarding Cardiovascular Health With Health Care Providers(6 months)
  • Number of Participants Stating Satisfaction With PREVENT Tool(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验